Patent delisted for Salix Pharms drug XIFAXAN

Annual Drug Patent Expirations for XIFAXAN Xifaxan is a drug marketed by Salix Pharms and is included in two NDAs. It is available from two suppliers. There are twenty-six patents…

The post Patent delisted for Salix Pharms drug XIFAXAN appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.